Finance

Lists
ACXP:NASDAQ
Acurx Pharmaceuticals Inc
$1.34
-1.47%
(-0.020) 1D
$1.33
-0.47% (-0.0063)
After hours
Closed: Sep 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACXP...
Open
$1.36
High
$1.36
Low
$1.33
Mkt. cap
7.45M
Avg. vol.
155.84K
Volume
52.78K
52-wk high
$8.34
52-wk low
$1.31
EPS
-$3.10
Beta
-2.02
Shares outstanding
5.56M
No. of employees
4
Open
$1.36
High
$1.36
Low
$1.33
Mkt. cap
7.45M
Avg. vol.
155.84K
Volume
52.78K
52-wk high
$8.34
52-wk low
$1.31
EPS
-$3.10
Beta
-2.02
Shares outstanding
5.56M
No. of employees
4
News stories
From web sources and news partners
About Acurx Pharmaceuticals Inc
CEODavid P Luci
Employees4
Founded2017
Headquarters-
SectorBiotechnology
Websiteacurxpharma.com
Analyst ratings
Based on 2 analysts giving stock ratings to ACXP in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ACXP in the last 3 months.
Highest
Current $1.34
$31.00 (+2,213.43%)
Average
$20.50 (+1,429.85%)
Lowest
$10.00 (+646.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+646.3%
08/17/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
$31.00
+2,213.4%
08/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$10.00
+646.3%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
429.69K
281.81K
341.47K
1.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.60M
1.34M
1.37M
1.24M
Operating expense
2.03M
1.62M
1.72M
2.31M
Total operating expenses
2.03M
1.62M
1.72M
2.31M
Operating income
-2.03M
-1.62M
-1.72M
-2.31M
Other non operating income
-
-
-
-
EBT including unusual items
-1.99M
-1.58M
-1.68M
-2.25M
EBT excluding unusual items
-1.99M
-1.58M
-1.68M
-2.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.99M
-1.58M
-1.68M
-2.25M
Net profit margin
-
-
-
-
Earnings per share
-1.23
-0.31
-0.62
-0.53
Interest and investment income
35.91K
38.84K
35.01K
53.06K
Interest expense
-
-
-
-
Net interest expenses
35.91K
38.84K
35.01K
53.06K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps